← Eichor
Study identifier: NCT05518305 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

Condition: Stroke · TIA · Ischemic Stroke  ·  Sponsor: University of California, Los Angeles

PhaseN/A
Planned participants250
Who can joinAll sexes, 30 Years to no upper limit
Healthy volunteersYes

About this study

An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.

This description comes directly from the study's public registry record.

Talk to the study team

David Liebeskind, MD  ·  ‭(310) 963-5539‬  ·  dliebeskind@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Ronald Reagan UCLA Medical CenterLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05518305